Similar Papers

Paper Title
Journal
Date
Author
POS1544 LONG-TERM SAFETY AND EFFICACY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS BY PRIOR BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG EXPOSURE
D D Gladman ... P Nash
Annals of the Rheumatic Diseases | VOL. 82
D D Gladman, et. al.D D Gladman ... P Nash
30 May 2023
P119 The Use of Exposure-Adjusted Event Rates versus Exposure-Adjusted Incidence Rates in Adverse Event Reporting: Insights from Filgotinib Integrated Safety Data in Rheumatoid Arthritis
Patrick Durez ... James Galloway
Rheumatology | VOL. 62
Patrick Durez, et. al.Patrick Durez ... James Galloway
24 Apr 2023
Deucravacitinib in Plaque Psoriasis: 4-year Safety and Efficacy Results from the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials
April W Armstrong ... Andrew Blauvelt
SKIN The Journal of Cutaneous Medicine | VOL. 8
April W Armstrong, et. al.April W Armstrong ... Andrew Blauvelt
18 Nov 2024
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years
April W Armstrong ... Andrew Blauvelt
JAMA Dermatology | VOL. 161
April W Armstrong, et. al.April W Armstrong ... Andrew Blauvelt
27 Nov 2024
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Dysfunctional KLRB1+CD8+ T-cell responses are generated in chronically inflamed systemic sclerosis skin.
Alyxzandria M Gaydosik ... Patrizia Fuschiotti
Annals of the rheumatic diseases | VOL. -
Alyxzandria M Gaydosik, et. al.Alyxzandria M Gaydosik ... Patrizia Fuschiotti
01 Feb 2025
Lipidomics unravels lipid changes in osteoarthritis articular cartilage.
Qiongfei Zhou ... Rik J Lories
Annals of the rheumatic diseases | VOL. -
Qiongfei Zhou, et. al.Qiongfei Zhou ... Rik J Lories
01 Feb 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.
Qingran Yan ... Oliver Distler
Annals of the rheumatic diseases | VOL. -
Qingran Yan, et. al.Qingran Yan ... Oliver Distler
01 Feb 2025
Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls.
Zahi Touma ... Miina Waratani
Annals of the rheumatic diseases | VOL. -
Zahi Touma, et. al.Zahi Touma ... Miina Waratani
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.